Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers

Condition:   Keratitis Interventions:   Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution;   Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor:   Peschke GmbH Not yet recruiting

Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials